Blog
RSS FeedPosted by Michael Wonder on 25 Oct 2018
Pharmaceutical industry challenges Trump plan forcing companies to reveal drug prices in TV ads
25 October 2018 - Symbicort, an inhaler marketed to people whose lung disease makes them “huff and puff,” rolls off ...
Posted by Michael Wonder on 23 Oct 2018
Drug companies, not 'middlemen', are responsible for high drug prices
22 October 2018 - As pharmaceutical companies have faced more heat for their pricing practices, they’ve found someone else to ...
Posted by Michael Wonder on 22 Oct 2018
Hatred of big pharma won’t get us better drug prices
22 October 2018 - The story of how Remicade became Canada’s most lucrative drug with sales topping $1.1-billion – told ...
Posted by Michael Wonder on 22 Oct 2018
How pharma companies try to use funding to sway patient advocate groups
21 October 2018 - Like many patient advocacy groups, the Canadian Spondylitis Association – which is focused on arthritis in the ...
Posted by Michael Wonder on 22 Oct 2018
What pharma giant Johnson & Johnson's CEO has to say about the drug price debate
18 October 2018 - “We’ve never seen time where the level of innovation has been richer and more exciting than what ...
Posted by Michael Wonder on 21 Oct 2018
What big pharma fears most: a Trump alliance with Democrats to cut drug prices
20 October 2018 - Pharmaceutical companies are conducting “war games” in anticipation of Democratic proposals that would squeeze their profits. ...
Posted by Michael Wonder on 20 Oct 2018
Is the EUnetHTA HTA core model fit for purpose? Evaluation from an industry perspective
18 October 2018 - The HTA Core Model was developed to improve the transferability of health technology assessment between settings. ...
Posted by Michael Wonder on 16 Oct 2018
Drug companies need to make costs more reasonable
16 October 2018 - Hundreds of women and their families marched on Parliament today to urge the funding of two ...
Posted by Michael Wonder on 15 Oct 2018
Drug industry will use ads to point consumers to price information
15 October 2018 - Stephen J. Ubl, president of the Pharmaceutical Research and Manufacturers of America, said prices in ads would ...
Posted by Michael Wonder on 11 Oct 2018
ABPI tells MPs Brexit deal on medicines regulation ‘urgently needed’
11 October 2018 - Pharmaceutical companies “are doing everything in their power” to minimise disruption to the supply of medicines ...
Posted by Michael Wonder on 01 Oct 2018
Abolishing drug rebates may push consumer drug costs higher
26 September 2018 - The Trump Administration has repeatedly said that controlling high drug prices is a top priority, and earlier ...
Posted by Michael Wonder on 26 Sep 2018
Big pharma boosts drug prices as supplies run low, study reveals
26 September 2018 - Federal lawmakers have been griping about drug pricing for years, led most recently by President Donald ...
Posted by Michael Wonder on 25 Sep 2018
Cost of clinical trials for new drug FDA approval are fraction of total tab
24 September 2018 - Clinical trials that support FDA approvals of new drugs have a median cost of $19 million, ...
Posted by Michael Wonder on 20 Sep 2018
Health insurer takes pharma giant to court for ‘evergreening’
20 September 2018 - Health insurance group Menzis is taking legal action against Astra Zeneca, accusing the pharmaceuticals firm of ...
Posted by Michael Wonder on 20 Sep 2018
Non-profit takes on drug makers' lobbying on Medicare drug discount
19 September 2018 - A group seeking lower drug prices is launching new attacks on the pharmaceutical industry to stop ...